Groups | Non-embolization Group | Embolization Group | Offending Embolization Group | P-Value |
---|---|---|---|---|
Number of Cases | 20 | 24 | 42 | |
Gender | 0.179 | |||
Male | 12 | 13 | 21 | |
Female | 8 | 11 | 21 | |
Age (Years) | 64.4±11.2 | 59.4±11.1 | 57.5±10.2 | 0.065 |
SINS | 11.2±2.9 | 12.7±2.3 | 11.6±3.2 | 0.260 |
ESCC Grade | 0.356 | |||
1 | 3 | 1 | 8 | |
2 | 8 | 7 | 15 | |
3 | 9 | 16 | 19 | |
Primary Cancer Renal Cancer 12 Thyroid Cancer 3 Breast Cancer 13 Lung Cancer 38 Prostate Cancer 7 Hepatic Cancer 3 Colon Cancer 1 Gastric Cancer 2 Esophageal Cancer 1 Bile Duct Cancer 1 Pancreatic Cancer 1 Cervical Cancer 3 Bladder Cancer 1 | 2 1 12 3 1 1 | 6 1 4 7 2 1 1 1 1 | 4 2 8 19 2 1 1 1 1 2 1 | |
Affected Part of Vertebra | ||||
Thoracic Vertebra | 2 | 14 | 19 | |
Lumbar Vertebra | 18 | 10 | 23 | |
Surgical Methods | 0.859 | |||
1 | 4 | 5 | 7 | |
2 | 5 | 7 | 15 | |
3 | 3 | 6 | 6 | |
4 | 8 | 6 | 14 |